Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Yang S, Li J, Han L, Zhu G
Metformin has the most extensive safety record and emerging longevity data
Several studies have suggested that DPP-4 inhibitors and GLP-1 analogs are more effective treatments for pasireotide-induced hyperglycemia than metformin or insulin therapy 25,26
While this effect contributes to weight loss and glycemic control by prolonging satiety and moderating glucose excursions, it can also produce gastrointestinal symptoms and affect perioperative care
24 A short-term, double-blind clinical study involving 426 patients with peripheral neuropathy of different etiologies, showed statistically meaningful differences between the ALC and placebo groups in terms of mean conduction velocity improvement
2009;6(1-4):e31-e39
US$ 23.12
US$ 28.21
US$ 27.51
US$ 20.50
